These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3149460)

  • 21. Five years' experience with intrauterine transfusion.
    Corston JM; Pereira E; Cudmore DW; Morton BS
    Can Med Assoc J; 1970 Sep; 103(6):594-9. PubMed ID: 5455275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intrauterine fetal transfusion in twin pregnancy with Rh isoimmunization].
    Vasileva Iu; Poissonier ME
    Akush Ginekol (Sofiia); 1989; 28(1):33-6. PubMed ID: 2500863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in intrauterine transfusion. Prof. Hansmann, Bonn, on ultrasound-controlled fine needle puncture of the fetus].
    Hansmann M
    Fortschr Med; 1990 Sep; 108(26):18, 21. PubMed ID: 2124575
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrauterine transfusion for severe isoimmunization.
    Perry SE; Parer JT; Inturrisi M
    MCN Am J Matern Child Nurs; 1986; 11(3):182-9. PubMed ID: 3088358
    [No Abstract]   [Full Text] [Related]  

  • 30. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of perinatal mortality from Rh isoimmunization.
    Peddle LJ; Hogan TG; McKilligin H; Dominic R; Simms DC
    Can Med Assoc J; 1971 Sep; 105(6):600-2. PubMed ID: 5000821
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravascular intra-uterine transfusions for severe fetal iso-immunisation--a new technique in South Africa.
    Muller LM; Steyn E; Meyer A
    S Afr Med J; 1993 Jan; 83(1):65. PubMed ID: 8424217
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rh sensitization].
    Drazancić A; Gorecan V; Barsić E
    Rad Med Fak Zagrebu; 1970; 18(2):89-105. PubMed ID: 4999735
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization].
    Calda P; Zizka Z; Rezábek K; Masata J; Bendl J
    Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrauterine fetal transfusions: Winnipeg 1982.
    Bowman JM; Manning FA
    Obstet Gynecol; 1983 Feb; 61(2):203-9. PubMed ID: 6823361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modern diagnosis and therapy of fetomaternal blood group incompatibility].
    Vetter K; Favre Y
    Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
    Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH
    Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 40. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.